Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
International Cardio
AddedFeb 18, 2024
UpdatedJun 18, 2026
International Cardio

International Cardio

Seed

International Cardio Corp: Global provider of non-invasive ultrasound solutions for artery disease.

HQ
Chaska, MN, US
Founded
2007
Overview
Compare
Fundraising
Employees
Website

International Cardio Corporation, founded in 2007 and based in Chaska, Minnesota, is dedicated to the research and development of high-intensity focused ultrasound (HIFU) solutions for the non-invasive treatment of peripheral artery disease. The company's core mission is to maximize patient safety while effectively managing therapeutic outcomes. Their flagship product, the HIFU Synthesizer™, is a pre-CE Mark medical device designed to image, target, and non-invasively ablate tissue with sub-millimeter precision.

Notable affiliated individuals include key researchers and developers in the field of medical ultrasound technology. International Cardio has achieved significant milestones in pre-clinical testing, demonstrating the efficacy and precision of their HIFU Synthesizer™. As a privately-held company, they have attracted interest from investors focused on innovative medical technologies. Overall, International Cardio's impact lies in advancing non-invasive treatment options for artery disease, potentially improving patient outcomes and reducing the need for more invasive surgical procedures.

International Cardio - Quick Facts

When was International Cardio founded?

International Cardio was founded in 2007.

Where is International Cardio's headquarters located?

International Cardio's headquarters is located in Chaska, MN, US.

When was International Cardio's last funding round?

International Cardio's most recent funding round was for $300k (USD) in December 2011.

How much has International Cardio raised to-date?

As of Dec 21, 2011, International Cardio has raised a total of $300k (USD).

How many employees does International Cardio have?

International Cardio has 6 employees as of Feb 5, 2024.

International Cardio - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Ultrasound
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 7 more industry codes
NAICS
  • 621000Ambulatory Health Care Services
  • 621400Outpatient Care Centers
  • 621490Other Outpatient Care Centers
  • 621491HMO Medical Centers
  • 623000Nursing and Residential Care Facilities
SIC
  • 8010Offices And Clinics Of Doctors Of Medicine
  • 8011Offices And Clinics Of Doctors Of Medicine